Background
==========

Cutaneous leishmaniasis (CL) is still considered as an important health problem in many parts of the world especially the Mediterranean and Middle East countries \[[@B1]-[@B4]\]. Difficulty in identifying these parasites due to the similar morphology of amastigotes of different *Leishmania*species has been solved using isoenzyme characterization \[[@B5]\]. This is the most common method used to study the variability of *Leishmania*spp. in general. Several PCR assays using specific primers were reported to be extremely sensitive and promising in the detection and identification of the New World \[[@B6]\] or Old World \[[@B7],[@B8]\] species of *Leishmania*directly in clinical samples. The first cases of CL in Jordan were reported by Adler and Theodor in 1929 \[[@B9]\]. No further reports appeared until 1968 when WHO reported 33 cases in East Jordan \[[@B10]\]. The endemicity of the region was recognized in the 1970s due to the increase in the number of cases diagnosed. A total of 524 cases were reported during 1973--1978, half of them occurred in the Jordan Valley \[[@B11]\]. Further information on human cases \[[@B12]\] sandfly vectors \[[@B13]\], and reservoir hosts \[[@B14]\] from several localities were reported on both the incidence and the spread of the disease to other geographical locations in Jordan. Cases of CL were reported from many locations in the country \[[@B2],[@B11],[@B12]\]; both *L. major*and *L. tropica*were reported. More cases of *L. major*were reported in the central part of the Jordan valley. Cases of *L. tropica*were more sporadic and reported mainly in the northern regions, species identification was based on the isoenzyme characterization \[[@B15]\].

While many facts of the epidemiology and clinical aspects of CL caused by *L. major*(dry type) and *L. tropica*(wet type) have been revealed, information on the parasites distribution and the epidemiologic factors governing their transmission are sparse. Zoonotic cutaneous leishmaniasis (ZCL) caused by *L. major*was reported for many years to be the only causative agent prevalent in Jordan mainly in rural areas \[[@B16]\]. In Jordan, the diagnosis of CL cases during the 1960s and 1970s was mainly reported in military hospitals in Amman \[[@B11]\]. Endemicity of the disease was ascertained after reporting a total of 524 cases during 1973--1978 \[[@B17]\]. Almost 50% of these cases came from the Jordan Valley, which is considered a hyper endemic region in Jordan. The Ministry of Health became increasingly aware of the seriousness of the leishmaniasis as a public health problem, procedures for the diagnosis and isolation of the parasite in cultures were added to their parasitologic procedures and isolates obtained were identified by isoenzyme characterization.

This study was initiated to investigate the emergence of the CL disease in new areas. It reports on the species identification and their zymodeme composition among *Leishmania*stocks isolated from human CL cases collected from different locations in the country during an eight year-period. Several new foci are reported for the first time indicating the spread of the disease. In addition, four previously undescribed *Leishmania*zymodemes are reported, of which three are endemic in Jordan and one isolated from an imported CL case.

Methods
=======

Subjects
--------

Patients clinically suspected of having CL were referred to the Ministry of Health, Central Laboratories in Amman, for parasitologic diagnosis during the period 1992--2000. These patients came from different governorates in Jordan mainly from cities and towns within 50 Km from Amman, the capital of Jordan.

For each case having cutaneous lesions (ulcers or scars), a questionnaire was completed to record the necessary information such as name, age, sex, sites of ulcer(s) on the body, address, date and place of acquiring the disease, previous travel history or location of work if other than the permanent address.

Parasitologic procedures
------------------------

Skin scrapings from the edge of the lesion were obtained from each patient. Part of it was immediately cultured in Evan\'s Modified Tobie\'s Medium with L-proline, foetal calf serum and antibiotics (gentamicin, nystatin or 5-Fluorocytosine as antifungal agent). Culture media were incubated at 22°C and examined at regular intervals to monitor the growth of the parasite or the presence of contaminants. The contaminated cultures were discarded. The remaining skin scraping portion was smeared on a slide for staining with Giemsa stain and examined microscopically for presence of amastigotes.

Isoenzyme characterization
--------------------------

Promastigote cultures isolated from specimens were air mailed to the *Leishmania*Reference Center of the Istituto Superiore di Sanità, Rome, Italy for cryopreservation and isoenzyme characterization. All *Leishmania*isolates were then cryopreserved, mass cultured in Brain Heart Infusion culture medium and characterized by starch-gel electrophoretic analysis of 13 isoenzymes (15 enzymic loci). The enzymes studied are: PGM, phosphogucomutase (E.C.2.7.5.1); GPI, glucose-phosphate isomerase (E.C.5.3.1.9); GOT, glutamate-oxaloacetate transmainase (E.C.2.6.1.1); ME, malic enzyme (E.C.1.1.1.40); 6PGD, glucose 6 phosphate dehydrogenase (E.C.1.1.1.49); G6PD, glucose 6 phosphate dehydrogenase (E.C.1.1.1.37); NP, nucleoside purine phosphorylase (E.C.3.2.2.1); MDH, malate dehydrogenase (E.C.1.1.1.37.), MPI, mannose phosphate isomerase (E.C.5.3.1.8); ICD, isocitrate dehydrogenase (E.C.1.1.1.42); DIA, diaphorase nicotinamide adenine dinucleotide (reduced form) (E.C.1.6.2.2); GLUD, glutamate dehydrogenase (E.C.1.4.1.3); FH, fumarate hydratase (E.C.4.2.1.2). The techniques employed and the zymodemes nomenclature adopted were those of Montpellier centre \[[@B18]\]. World Health Organization (WHO) reference strains of *L. infantum*zymodeme (Z) MON-1 (MHOM/TN/80/IPT1), *L. donovani*ZMON-2 (MHOM/IN/80/DD8), *L. tropica*ZMON-60 (MHOM/SU/74/K27) and *L. major*ZMON-4 (MHOM/SU/73/5-ASKH) were used as references. Furthermore, strains of *L. tropica*and *L. major*zymodemes previously isolated in Jordan and neighboring countries were also used as references. When a new zymodeme was identified, this was provisionally named as \"variant\" (var) from the most similar classified MON zymodeme, and the electrophoretic mobility of the variant enzyme(s) was reported along.

Phenetic analysis
-----------------

For the taxonomic study 17 operational taxonomic units (OTUs) corresponding to the zymodemes, were used. Of these, 12 were included in the phylogenetic complexes reported by Rioux et al (1993)\[[@B19]\]; 6 in the *L. tropica*complex (ZMON-54, 59, 60, 75, 76 and 137), 5 in the *L. major*complex (ZMON-4, 26, 68, 103, 229) and 1 in the *L. infantum*complex (ZMON-1); 1 was a *L. tropica*zymodeme from the Arabic Peninsula (71-var PGD~95~, G6PD~85~, NP1~450~, NP2~100~, FH~100~); and finally, 4 were the new zymodemes detected during the present study. Apart from the three WHO reference zymodemes of *L. infantum*(MON-1), *L. tropica*(MON-60) and *L. major*(MON-4), all the other zymodemes were from the Middle East, ex Soviet Union, Afghanistan, Yemen and Arabic Peninsula.

The phenogram was built using the UPGMA method \[[@B20]\] based on the Jaccard similarity index values (Sj), as implemeted by the NTSYS-pc computer software.

Results
=======

Epidemiologic data
------------------

Parasites were isolated in culture from skin ulcers with detailed sociodemographic data from 76 patients.

The age groups and sex distribution for both species are shown in Table [1](#T1){ref-type="table"}. The highest infection rate of 72.4% was recorded in males compared to 27.6% in females. The age range of the patients was from 10 months to 64 years while that for*L. tropica*was from 7 months to 54 years. Infections with *L. major*were recorded in 48 males (84.2%) and in 9 females (15.8%). The opposite was recorded in *L. tropica*, where higher infection rates were recorded in females (63.2%) than in males (36.8%). The highest rates in both species were recorded in adults in the age group 21--30 years (30.5%) and in children less than five years (23.7%), followed by 10.5% in the age groups of 11--20, 31--40, and 41--50 years. The lowest rates (6.6% and 7.7%) were recorded in the age groups 5--10 years, and \> 50 years respectively.

###### 

Distribution of 76 cutaneous leishmaniasis cases by age and sex

  **Age group (years)**   ***L. major***   ***L. tropica***   **Total No. of cases (%)**        
  ----------------------- ---------------- ------------------ ---------------------------- ---- -----------
  \< 5                    12               2                  2                            2    18 (23.7)
  5--10                   1                1                  1                            2    5 (6.6)
  11--20                  3                2                  1                            2    8 (10.5)
  21--30                  18               2                  1                            2    23 (30.5)
  31--40                  5                1                  1                            1    8 (10.5)
  41--50                  5                0                  1                            2    8 (10.5)
  \> 50                   4                1                  0                            1    6 (7.7)
  Total                   48               9                  7                            12   76 (100)

\* M: males \*\* F: females

Lesions were mainly located on the face and neck (47%) compared with (20%) on the hands and arms, and (17%) on the legs. Multiple lesions appeared on two or more sites of the body in 16% of the cases.

Patient\'s residence, working place, travel history and the time of appearance of the lesions were important data for determining the locations where the infections might have taken place. The numbers of positive cases in the north, central and south parts of Jordan are shown in Table [2](#T2){ref-type="table"}. The highest infection rate (60.5%) was recorded in patients who are living or contracted the disease in the central part of Jordan (Figure [1](#F1){ref-type="fig"}) followed by the infection rate (14.5%) recorded for patients from the north. The lowest rate (13.2%) was recorded for patients living or contracted the disease in the south. The infection rate in patients who contracted the disease in the neighboring countries was 11.8 %. These patients worked and lived outside Jordan previous to the appearance of the lesions. The countries where they contacted the disease were Saudi Arabia (three in Taif and two in Riyadh), Iraq (two in Baghdad) and Syria (two in Aleppo); these countries are known to be endemic with CL.

![Distribution of cutaneous leishmaniasis cases in Jordan during 1992--2000.](1475-9292-1-7-1){#F1}

###### 

Infection rates in patients from different regions of Jordan

  **Region**   **No. of cases examined (%)**   **No. of positive (%)**
  ------------ ------------------------------- -------------------------
  North        70 (21.9)                       11 (14.5)
  Central      180 (56.3)                      46 (60.5)
  South        44 (13.7)                       10 (13.2)
  Imported     26 (8.1)                        9 (11.8)

Parasite species and zymodemes
------------------------------

*L. major*and *L. tropica*were isolated from patients coming from Jordan and neighbouring countries. The zymodemes of *Leishmania*spp. that were isolated varied from one region to another as reported in Table [3](#T3){ref-type="table"}. A total of eight zymodemes were identified, of which four previously unreported. Zymodeme composition is reported in Tables [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}. Three *L. major*zymodemes were identified as autochthonous in Jordan. In the North of the country ZMON-103 was isolated from Malka and ZMON-103 var GLUD~220~(reference strain MHOM/JO/94/JCL50) was a newly described variant isolated from patients in Northern Jordan Valley. In the Central region three zymodemes were isolated: ZMON-103 (e.g. Amman, Salt, S. Shouneh), ZMON-103 var GLUD~220~(S. Shouneh), and MON-229 (Karameh). Finally, *L. major*ZMON-103 was isolated from a patient from Karak in the South of the country.

###### 

The isolated *Leishmania*spp, their zymodemes identification and infection location

  **Infection location**   ***L. major*zymodemes**                     ***L. tropica*zymodemes**
  ------------------------ ------------------------------------------- --------------------------------------------------------------
  North                    MON-103, MON-103 var GLUD~220~\*            MON-54 var PGD~96--97~
  Central                  MON-103, MON-103 var GLUD~220~\*, MON-229   MON-137, MON-54 var PGD96-97
  South                    MON-103                                     MON-59 var MDH~100~, PGD~95~, G6PD~85~, GLUD~80~, MPI~110~\*
  Other countries                                                      
  Aleppo, Syria                                                        MON-75 FH~110~\*
  Riyadh, Saudi Arabia     MON-26                                      MON-59 var MDH~100~, PGD~95~, G6PD~85~, GLUD~80~, MPI~110~\*
  Taif, Saudi Arabia                                                   MON-59 var MDH100, PGD95, G6PD85, GLUD80, FH110\*

\* Newly described enzymatic variant

###### 

Enzyme profiles of the *Leishmania tropica*zymodemes identified from autochthonous and imported CLcases in Jordan

  **Zymodeme MON**   **ENZYMES**                                                                                                        
  ------------------ ------------- ----- ----- ------------ -------- -------- ----- ----- ----- ------ ------ ----- --------- --------- -----
                     MDH           ME    IDH   PGD          G6PD     GLUD     DIA   NP1   NP2   GOT1   GOT2   PGM   FH        MPI       PGI
                                                                                                                                        
  137                100           110   100   98           85       80       100   450   110   140    85     88    100       110       76
  54 var\*           112           95    100   **96--97**   82       80       120   450   90    135    90     100   110       100       76
  59 var\*\*         **100**       100   100   **95**       **85**   **80**   100   450   100   135    90     100   100       **110**   76
  75 var\*\*\*       112           95    100   95           82       95       100   450   100   135    90     100   **110**   101       76

\* ZMON-54 PGD~96--97~var; \*\* ZMON59 MDH~100~, PGD~95~, G6PD~85~, GLUD~80~, MPI~110~var; \*\*\* ZMON-75 FH~110~var

###### 

Enzymes profiles of the *Leishmania major*zymodemes identified from autochthonous and imported CL cases in Jordan

  **Zymodemes MON**   **ENZYMES**                                                                                      
  ------------------- ------------- ---- ----- ----- ------ --------- ----- ----- ----- ------ ------ ----- ---- ----- -----
                      MDH           ME   IDH   PGD   G6PD   GLUD      DIA   NP1   NP2   GOT1   GOT2   PGM   FH   MPI   PGI
                                                                                                                       
  26                  160           88   100   122   94     200       100   400   90    110    110    118   79   150   77
  103                 160           88   100   122   94     200       100   400   100   110    110    118   79   150   77
  103 var\*           160           88   100   122   94     **220**   100   400   100   110    110    118   79   150   77
  229                 160           90   100   122   94     200       100   400   90    110    110    118   79   150   77

\*: ZMON-103 var GLUD~220~

Three *L. tropica*zymodemes were identified from autochthonous CL cases in Jordan. *L. tr*opica ZMON-54 var PGD~96--97~(reference strain MHOM/JO/94/JCL34) was isolated from the North (e.g. Um Qais, Hammeh,) of the country. In the Central region (e.g. S. Shouneh) ZMON-54 var PGD~96--97~and ZMON-137 were isolated. A newly described variant, ZMON-59 var MDH~100~, PGD~95~, G6PD~85~, GLUD~80~, MPI~110~(reference strain MHOM/JO/92/JCL27) was isolated from the South (Tafila).

Both *Leishmania*species were also isolated from patients who contracted the disease during their work in the neighboring countries. *L. major*ZMON-26 was isolated from two patients living in Riyadh, Saudi Arabia. *L. tropica*ZMON-59 var MDH~100~, PGD~95~, G6PD~85~, GLUD~80~, MPI~110~was isolated from two patients who contracted the disease in Taif, Saudi Arabia. *L. tropica*ZMON-75 var FH~110~(reference strain MHOM/SY/93/JCL29), which is a newly described zymodeme, AND was isolated from a patient who contracted the disease in Aleppo, Syria.

*L. major*ZMON-103 was also isolated from four jirds that were caught in the central rural area.

Phenetic analysis
-----------------

The phenogram in Figure [2](#F2){ref-type="fig"} shows 2 principal branches clearly individualized, with a third branch supported by *L. infantum*(A). The first branch (B) is highly polymorphic with a first branch at Sj value as low as 0.27, and includes all the zymodemes of *L. tropica*. The second one (C) is more monomorphic (Sj = 0.70) and includes the group of *L. major*zymodemes. *L. infantum*links to *L. tropica*delimiting two principal clusters of this species: a) the first one is made of 7 zymodemes that show links between the WHO reference MON-60 (from ex Soviet Union) and MON-76 (from Syria); between MON75 (from ex Soviet Union) and the new zymodeme MON-75 var FH~110~(Sj = 0.76); and between the close pair MON-54 (from Israel) and the new zymodeme MON-54 var PGD~96--97~(Sj = 0.87); MON-59 (from Afghanistan) is grouped as a single entity; b) the second cluster is made of 3 zymodemes, of which MON-137 (from Israel) links to a group of very similar zymodemes MON-59 var MDH~100~, PGD~95~, G6PD~85~, GLUD~80~, MPI~110~and MON-71 var PGD~95~, G6PD~85~, NP1~450~, NP2~100~, FH~100~(from Arabic Peninsula) (Sj = 0.76). As regards *L. major*, two principal clusters are identified: a) the first closely links zymodemes MON-4 (WHO reference from ex Soviet Union) and MON 26 (from Yemen) (Sj = 0.87) to ZMON-229 from Jordan; b) the second identifies the paired MON-103 from Jordan and the new zymodeme MON-103 var GLUD~220~(Sj = 0.87). As external group MON-68 from Israel links *L. major*to *L. infantum*. (Sj = 0.17), confirming the high distance between the two species \[[@B21]\]

![Phenogram built on 15 enzymatic loci from 3 WHO *Leishmania*reference strains and 14 *Leishmania*zymodemes from Middle East and Central Asia (similarity Jaccard index (Sj); UPGMA method). Three groups are identified: *Leishmania infantum*(A, triangle), *L. tropica*(B, circles) and *L. major*(C, squares).](1475-9292-1-7-2){#F2}

Discussion
==========

This study reports on cases of human CL caused by *L. major*and *L. tropica*from different regions in Jordan. Figure [1](#F1){ref-type="fig"} shows the locations where cases are reported in this study. Cases are reported for the first time from cities in the north (e.g., Kufrsoum, Kufrangeh, and Saham), the central region (e.g. Azraq, Falha) and the south (e.g., Aqaba, Al Hasa, Karak, and Tafila). The sporadic nature of the cases in these areas indicates the recent spread of the disease to these areas. Clustering of cases was recorded in endemic areas along the Jordan Valley; highest number of cases was reported mostly in the central part. Several studies reported on the endemicity of CL on both sides of the Jordan Valley \[[@B11],[@B13],[@B22]\]. The disease is endemic for many years in Jericho (Jericho boil), the endemicity of the disease has been maintained due to the presence of the vector *Phlebotomus papatasi*, and the reservoir host *Psammomys obesus*in that area \[[@B22]\].

The highest number of cases reported in our study was mainly in the central part of Jordan (Karameh, S. Shouneh and Sweimeh). These results are in agreement with previous studies, which also reported higher infection rates in Sweimeh in the Jordan Valley \[[@B17]\]. The number of cases diagnosed in one military hospital in Amman during 1979 through 1981 was 207 cases, where 71% of these came from the same area, Sweimeh in the Jordan Valley. A report of an outbreak of zoonotic CL in 80 nonimmuned soldiers in Southern Jordan confirmed the endemicity of the disease in the Jordan Valley \[[@B23]\].

The infection rates reported in the north particularly along the Jordan Valley came second. Isolation of the parasite from new areas indicates that the geographical distribution of CL in Jordan is far wider than previously thought.

The higher infection rates (72.4%) recorded in males compared to females (27.6%) in all age groups were also reported by others \[[@B12]\]. This difference might be explained by more exposure of males to the sandflies bites during their travel and work activities in the endemic areas. The high rates in children less than five years old (23.7%) might be explained by non immunity and frequent exposure to bites of the sandflies inside their homes since most of the cases in this age group were from the central endemic areas (e.g., S. Shouneh and Sweimeh) and other cities in the south (e.g., Aqaba and Al Hasa). The low rates recorded in the age group \> 50 years (7.7%) might be explained by development of immunity over time as a result of previous exposure, which is well known in CL. The low rate in the age group 5--10 years (6.6%) could not be explained. It might be due to the exclusion of some of the cases in this age group among other cases due to incomplete information about the patients.

In a study of the distribution of phlebotomine sandfly species in Jordan \[[@B16]\], *Phlebotomus papatasi*, the vector of *L. major*was collected from both domestic and rural areas in many localities in Jordan. It was reported as the predominant or the abundant species in localities where cases were reported in this study such as the Jordan Valley, suburbs of Amman and in the newly reported localities such as Azraq, and Aqaba. Evidence on the role of *P. papatasi*as a vector of *L. major*was provided after the isolation of the parasite from *P. papatasi*females collected from the Southern Jordan Valley \[[@B13]\]. *L. major*was also isolated from four *Psammomys obesus*, the principle reservoir host caught in endemic foci in Jordan \[[@B14]\]. CL is also known to be endemic in the neighboring countries where nine patients contracted the disease \[[@B24]-[@B26]\]. *L. major*was the predominant species (75%) that was isolated from all localities in this study and in previous studies \[[@B13],[@B14]\]. CL caused by *L. tropica*is less common in Jordan as well as in the other endemic neighboring countries \[[@B27],[@B28]\]. *L. tropica*was mainly isolated from the north, few cases from the central region, and one case in the south. It was also isolated from cases imported from Saudi Arabia and Syria where it is endemic \[[@B24],[@B29]\].

The isoenzyme characterization of the isolates identified four *L. major*zymodemes MON-26, MON-103 (the predominant zymodeme), and MON-103 var GLUD220 (newly described enzymatic variant), MON-229 and MON-26, from an imported CL case from Saudi Arabia. As already reported for this species, a general enzymatic homogeneity among the strains was observed, variations being limited to 1--2 enzymes only (Tab. [5](#T5){ref-type="table"}, Fig. [2](#F2){ref-type="fig"}). *L. major*zymodeme MON-26 is known as the agent of ZCL in the sub-Saharan Sahel to the Near and Middle East \[[@B30]\].

Four *L. tropica*zymodemes were identified, MON-137, MON-54 var PGD~96--97~, MON-59 var MDH~100~, PGD~95~, G6PD~85~, GLUD~80~, MPI~110~, and MON-75 var FH~110~, the last three being newly described zymodemes. Zymodeme MON-59 var MDH~100~, PGD~95~, G6PD~85~, GLUD~80~, MPI~110~was identified in both autochthonous (Tafila) and in imported cases from Saudi Arabia, while zymodeme MON-75 var FH~110~was only identified from imported cases from Aleppo, Syria. *L. tropica*zymodemes differed in one to five enzymes, confirming the high degree of intraspecific polymorphism reported for this species (Tab. [4](#T4){ref-type="table"}, Fig. [2](#F2){ref-type="fig"}). Diversification into \"small variants\" is apparently the result of recent mutations, possibly associated with genetic exchange \[[@B31]\]. Unlike *L. major*, which is known to have a zoonotic transmission cycle, the transmission cycle of *L. tropica*is mainly anthroponotic and associated to urban environment. If the transmission cycle in the areas where it was isolated is man-fly-man, then the geographical distribution of intraspecific variants will be greatly influenced by the movement of the infected individuals. Thus a zymodeme may be spread from city to city, becoming established if the species of the sandfly vector is present. This could explain the wide distribution of zymodeme MON-54 var PGD~96--97~identified in cases from the north and the central regions. An explanation for the greater variation noticed in *L. tropica*than *L. major*may be that *L. tropica*simply has greater genetic diversity than *L. major*.

The importance of finding an isoenzymatic variant could be applied to identify a geographical entity, with the possibility of identifying the origin of the infection especially in highly polymorphic *Leishmania*species such as *L. tropica*, when an appropriate panel of isoenzymes is analyzed. The phenetic analysis confirms this hypothesis linking zymodemes for similarity distance according their geographical origin. Then most zymodemes from Middle East are progressively linked (Figure [2](#F2){ref-type="fig"}). Although in some *Leishmania*species the enzymatic variation of an isolate could also be used as a clinical marker (for example NP1~140~in *L. infantum*could be used as a marker for cutaneous, rather than visceral leishmaniasis ; however, it seems that no \"clinical\" association is evident for different *L. tropica*zymodemes.

To our knowledge, this is the first study that reports on zymodemes of both *L. major*and *L. tropica*isolated from different parts of the country. *L. tropica*with isoenzyme profiles characteristics resembling MON-54 that was reported for eight isolates from towns in the north \[[@B15]\] is confirmed by isolating ZMON-54 var PGD~96--97~from the same towns in this study. The isolation of *L. major*ZMON-103 from Salt in this study and *L. tropica*ZMON-137 from Salt district in another study \[[@B32]\], indicates the presence of both spp. in the same area and calls for further investigation on the status of the disease in that area.

Conclusions
===========

Based on the findings of this study, the new localities where cases were reported should be added to the list of CL foci. The data clearly demonstrate the clustering of cases in endemic areas and the spread of the disease to new areas that were not previously reported indicated by the sporadic nature of the disease in these areas. Further studies on the vector and reservoir host are needed to investigate the transmission cycle in these areas.
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